Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Indapamide.
Acebutolol
Indapamide may increase the hypotensive activities of Acebutolol.
Aceclofenac
The therapeutic efficacy of Indapamide can be decreased when used in combination with Aceclofenac.
Advertisement
Acemetacin
The therapeutic efficacy of Indapamide can be decreased when used in combination with Acemetacin.
Acetohexamide
The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Indapamide.
Acetyl salicylate
The therapeutic efficacy of Indapamide can be decreased when used in combination with Acetylsalicylic acid.
Advertisement
Acetyl Sulfisoxazole
The metabolism of Indapamide can be decreased when combined with Acetyl sulfisoxazole.
Acetyldigitoxin
The risk or severity of adverse effects can be increased when Indapamide is combined with Acetyldigitoxin.
Aclidinium
The serum concentration of Indapamide can be increased when it is combined with Aclidinium.
Advertisement
Adapalene
The therapeutic efficacy of Indapamide can be decreased when used in combination with Adapalene.
Albuterol
Salbutamol may increase the hypokalemic activities of Indapamide.
Alclometasone
Alclometasone may increase the hypokalemic activities of Indapamide.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Indapamide.
Aldosterone
Aldosterone may increase the hypokalemic activities of Indapamide.
Alfacalcidol
The risk or severity of hyperkalemia can be increased when Alfacalcidol is combined with Indapamide.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Indapamide.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Indapamide.
Aliskiren
Indapamide may increase the hypotensive activities of Aliskiren.
Allopurinol
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Indapamide.
Alminoprofen
The therapeutic efficacy of Indapamide can be decreased when used in combination with Alminoprofen.
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Indapamide.
Alphaprodine
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Indapamide.
Alprenolol
Indapamide may increase the hypotensive activities of Alprenolol.
Ambrisentan
Indapamide may increase the hypotensive activities of Ambrisentan.
Amcinonide
Amcinonide may increase the hypokalemic activities of Indapamide.
Amifostine
Indapamide may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Indapamide may increase the hypotensive activities of Amifostine.
Amiloride
The risk or severity of adverse effects can be increased when Amiloride is combined with Indapamide.
Amiodarone
The metabolism of Indapamide can be decreased when combined with Amiodarone.
Amlodipine
Amlodipine may increase the hypotensive activities of Indapamide.
Amobarbital
Amobarbital may increase the orthostatic hypotensive activities of Indapamide.
Amphetamine
Amphetamine may increase the hypotensive activities of Indapamide.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Indapamide.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Indapamide.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Indapamide is combined with Amyl Nitrite.
Anagrelide
Indapamide may increase the QTc-prolonging activities of Anagrelide.
Androstenedione
Androstenedione may increase the hypokalemic activities of Indapamide.
Antipyrine
The therapeutic efficacy of Indapamide can be decreased when used in combination with Antipyrine.
Apalutamide
The serum concentration of Indapamide can be decreased when it is combined with Apalutamide.
Apazone
The therapeutic efficacy of Indapamide can be decreased when used in combination with Azapropazone.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Indapamide.
Apraclonidine
The risk or severity of adverse effects can be increased when Indapamide is combined with Apraclonidine.
Apremilast
The therapeutic efficacy of Indapamide can be decreased when used in combination with Apremilast.
Aprepitant
The serum concentration of Indapamide can be increased when it is combined with Aprepitant.
Arbutamine
Arbutamine may increase the hypokalemic activities of Indapamide.
Arformoterol
Arformoterol may increase the hypokalemic activities of Indapamide.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Indapamide.
Arsenic Trioxide
Indapamide may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
Indapamide may increase the QTc-prolonging activities of Artemether.
Asenapine
Indapamide may increase the QTc-prolonging activities of Asenapine.
Aspirin
The therapeutic efficacy of Indapamide can be decreased when used in combination with Acetylsalicylic acid.
Atazanavir
The metabolism of Indapamide can be decreased when combined with Atazanavir.
Atenolol
Atenolol may increase the hypotensive activities of Indapamide.
Atomoxetine
The metabolism of Indapamide can be decreased when combined with Atomoxetine.
Atracurium
The serum concentration of Indapamide can be increased when it is combined with Atracurium.
Atracurium Besylate
The serum concentration of Indapamide can be increased when it is combined with Atracurium besylate.
Atropine
The serum concentration of Indapamide can be increased when it is combined with Atropine.
Avanafil
Avanafil may increase the antihypertensive activities of Indapamide.
Azelastine
The therapeutic efficacy of Indapamide can be decreased when used in combination with Azelastine.
Azilsartan
The risk or severity of adverse effects can be increased when Indapamide is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Indapamide is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Indapamide is combined with Azilsartan medoxomil.
Azithromycin
Indapamide may increase the QTc-prolonging activities of Azithromycin.
Balsalazide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Balsalazide.
Bambuterol
Bambuterol may increase the hypokalemic activities of Indapamide.
Barbexaclone
Barbexaclone may increase the orthostatic hypotensive activities of Indapamide.
Barbital
Barbital may increase the orthostatic hypotensive activities of Indapamide.
Beclomethasone Dipropionate
Beclomethasone dipropionate may increase the hypokalemic activities of Indapamide.
Bedaquiline
Indapamide may increase the QTc-prolonging activities of Bedaquiline.
Benactyzine
The serum concentration of Indapamide can be increased when it is combined with Benactyzine.
Benazepril
The risk or severity of hypotension can be increased when Indapamide is combined with Benazepril.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Indapamide.
Benztropine
The serum concentration of Indapamide can be increased when it is combined with Benzatropine.
Benzydamine
The therapeutic efficacy of Indapamide can be decreased when used in combination with Benzydamine.
Bepridil
Indapamide may increase the hypotensive activities of Bepridil.
Betamethasone
Betamethasone may increase the hypokalemic activities of Indapamide.
Betaxolol
Betaxolol may increase the hypotensive activities of Indapamide.
Bethanidine
Bethanidine may increase the hypotensive activities of Indapamide.
Bimatoprost
Indapamide may increase the hypotensive activities of Bimatoprost.
Biperiden
The serum concentration of Indapamide can be increased when it is combined with Biperiden.
Bisoprolol
Bisoprolol may increase the hypotensive activities of Indapamide.
Bitolterol
Bitolterol may increase the hypokalemic activities of Indapamide.
Bitolterol Mesylate
Bitolterol may increase the hypokalemic activities of Indapamide.
Boceprevir
The metabolism of Indapamide can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Indapamide can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Indapamide can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Indapamide can be decreased when it is combined with Bosentan.
Bretylium
Indapamide may increase the hypotensive activities of Bretylium.
Brimonidine
Brimonidine may increase the antihypertensive activities of Indapamide.
Bromfenac
The therapeutic efficacy of Indapamide can be decreased when used in combination with Bromfenac.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Indapamide.
Budesonide
Budesonide may increase the hypokalemic activities of Indapamide.
Bufexamac
The therapeutic efficacy of Indapamide can be decreased when used in combination with Bufexamac.
Bumetanide
The risk or severity of adverse effects can be increased when Indapamide is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Indapamide.
Bupranolol
Indapamide may increase the hypotensive activities of Bupranolol.
Buprenorphine
The risk or severity of adverse effects can be increased when Buprenorphine is combined with Indapamide.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Indapamide.
Butylscopolamine
The serum concentration of Indapamide can be increased when it is combined with Butylscopolamine.
Cafedrine
Indapamide may increase the hypotensive activities of Cafedrine.
Calcifediol
The risk or severity of hyperkalemia can be increased when Calcidiol is combined with Indapamide.
Calcifediol Anhydrous
The risk or severity of hyperkalemia can be increased when Calcidiol is combined with Indapamide.
Calcipotriene
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Indapamide.
Calcitriol
The risk or severity of hyperkalemia can be increased when Calcitriol is combined with Indapamide.
Calcium Acetate
Indapamide may decrease the excretion rate of Calcium Acetate which could result in a higher serum level.
Calcium Carbonate
Indapamide may decrease the excretion rate of Calcium Carbonate which could result in a higher serum level.
CALCIUM CARBONATE, PRECIPITATED
Indapamide may decrease the excretion rate of Calcium Carbonate which could result in a higher serum level.
Calcium Chloride
Indapamide may decrease the excretion rate of Calcium Chloride which could result in a higher serum level.
Calcium Chloride Anhydrous
Indapamide may decrease the excretion rate of Calcium Chloride which could result in a higher serum level.
Calcium Citrate
Indapamide may decrease the excretion rate of Calcium Citrate which could result in a higher serum level.
Calcium Glubionate
Indapamide may decrease the excretion rate of Calcium glubionate which could result in a higher serum level.
Calcium gluceptate
Indapamide may decrease the excretion rate of Calcium Gluceptate which could result in a higher serum level.
Calcium Gluconate
Indapamide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level.
Calcium Lactate
Indapamide may decrease the excretion rate of Calcium lactate which could result in a higher serum level.
CALCIUM LEVULINATE
Indapamide may decrease the excretion rate of Calcium levulinate which could result in a higher serum level.
Canagliflozin
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Indapamide.
Canagliflozin Anhydrous
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Indapamide.
Candesartan
Indapamide may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Indapamide.
Captopril
The risk or severity of hypotension can be increased when Indapamide is combined with Captopril.
Carbamazepine
The risk or severity of adverse effects can be increased when Indapamide is combined with Carbamazepine.
Carprofen
The therapeutic efficacy of Indapamide can be decreased when used in combination with Carprofen.
Carteolol
Carteolol may increase the hypotensive activities of Indapamide.
Carvedilol
Indapamide may increase the hypotensive activities of Carvedilol.
Casein Allergenic Extract
Indapamide may decrease the excretion rate of Casein which could result in a higher serum level.
Celecoxib
The therapeutic efficacy of Indapamide can be decreased when used in combination with Celecoxib.
Celiprolol
Celiprolol may increase the hypokalemic activities of Indapamide.
Ceritinib
The serum concentration of Indapamide can be increased when it is combined with Ceritinib.
Chloroquine
The therapeutic efficacy of Indapamide can be decreased when used in combination with Chloroquine.
Chlorothiazide
Indapamide may increase the hypotensive activities of Chlorothiazide.
Chlorphenoxamine
The serum concentration of Indapamide can be increased when it is combined with Chlorphenoxamine.
Chlorpromazine
Indapamide may increase the QTc-prolonging activities of Chlorpromazine.
Chlorpropamide
The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Indapamide.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Indapamide.
Cholecalciferol
The risk or severity of hyperkalemia can be increased when Cholecalciferol is combined with Indapamide.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Indapamide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The therapeutic efficacy of Indapamide can be decreased when used in combination with Choline magnesium trisalicylate.
Ciclesonide
Ciclesonide may increase the hypokalemic activities of Indapamide.
Cicletanine
Indapamide may increase the hypotensive activities of Cicletanine.
Cilazapril
The risk or severity of hypotension can be increased when Indapamide is combined with Cilazapril.
Ciprofloxacin
Indapamide may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Indapamide may increase the QTc-prolonging activities of Cisapride.
Citalopram
Indapamide may increase the QTc-prolonging activities of Citalopram.
Clarithromycin
The metabolism of Indapamide can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Indapamide can be decreased when combined with Clemastine.
Clenbuterol
Clenbuterol may increase the hypokalemic activities of Indapamide.
Clevidipine
The risk or severity of adverse effects can be increased when Indapamide is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Indapamide is combined with Clevidipine.
Clobetasol
Clobetasol may increase the hypokalemic activities of Indapamide.
Clobetasol Propionate
Clobetasol propionate may increase the hypokalemic activities of Indapamide.
Clobetasone
Clobetasone may increase the hypokalemic activities of Indapamide.
Clocortolone
Clocortolone may increase the hypokalemic activities of Indapamide.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Indapamide.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Indapamide.
Clonidine
Clonidine may increase the hypotensive activities of Indapamide.
Clonixin
The therapeutic efficacy of Indapamide can be decreased when used in combination with Clonixin.
Clotrimazole
The metabolism of Indapamide can be decreased when combined with Clotrimazole.
Clozapine
Indapamide may increase the QTc-prolonging activities of Clozapine.
Cobicistat
The metabolism of Indapamide can be decreased when combined with Cobicistat.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Indapamide.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Indapamide.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Indapamide.
Colesevelam
Colesevelam can cause a decrease in the absorption of Indapamide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Indapamide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Indapamide.
Cortisone Acetate
Cortisone acetate may increase the hypokalemic activities of Indapamide.
Crizotinib
The metabolism of Indapamide can be decreased when combined with Crizotinib.
Cryptenamine
Cryptenamine may increase the hypotensive activities of Indapamide.
Curcumin
The metabolism of Indapamide can be decreased when combined with Curcumin.
Cyclopenthiazide
Indapamide may increase the hypotensive activities of Cyclopenthiazide.
Cyclopentolate
The serum concentration of Indapamide can be increased when it is combined with Cyclopentolate.
Cyclophosphamide
The risk or severity of severe leukopenia can be increased when Indapamide is combined with Cyclophosphamide.
Cyclophosphamide Anhydrous
The risk or severity of severe leukopenia can be increased when Indapamide is combined with Cyclophosphamide.
Cyclosporine
The metabolism of Indapamide can be decreased when combined with Cyclosporine.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Indapamide.
Dabrafenib
The serum concentration of Indapamide can be decreased when it is combined with Dabrafenib.
Dapagliflozin
The risk or severity of adverse effects can be increased when Indapamide is combined with Dapagliflozin.
Darifenacin
The serum concentration of Indapamide can be increased when it is combined with Darifenacin.
Darunavir
The metabolism of Indapamide can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Indapamide can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Indapamide can be increased when it is combined with Dasatinib.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Indapamide.
Deferasirox
The serum concentration of Indapamide can be decreased when it is combined with Deferasirox.
Deflazacort
Deflazacort may increase the hypokalemic activities of Indapamide.
Delavirdine
The metabolism of Indapamide can be decreased when combined with Delavirdine.
Deserpidine
Indapamide may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Indapamide.
Deslanoside
The risk or severity of adverse effects can be increased when Indapamide is combined with Deslanoside.
Desloratadine
The serum concentration of Indapamide can be increased when it is combined with Desloratadine.
Desonide
Desonide may increase the hypokalemic activities of Indapamide.
Desoximetasone
Desoximetasone may increase the hypokalemic activities of Indapamide.
Desoxycorticosterone acetate
Desoxycorticosterone acetate may increase the hypokalemic activities of Indapamide.
Desoxycorticosterone Pivalate
Desoxycorticosterone Pivalate may increase the hypokalemic activities of Indapamide.
Desvenlafaxine
Desvenlafaxine may increase the hyponatremic activities of Indapamide.
Dexamethasone
Dexamethasone may increase the hypokalemic activities of Indapamide.
Dexetimide
The serum concentration of Indapamide can be increased when it is combined with Dexetimide.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Indapamide.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Indapamide.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Indapamide.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Indapamide.
Diazoxide
The risk or severity of adverse effects can be increased when Indapamide is combined with Diazoxide.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Indapamide is combined with Diclofenamide.
Diclofenac
The therapeutic efficacy of Indapamide can be decreased when used in combination with Diclofenac.
Dicyclomine
The serum concentration of Indapamide can be increased when it is combined with Dicyclomine.
Diflorasone
Diflorasone may increase the hypokalemic activities of Indapamide.
Diflucortolone
Difluocortolone may increase the hypokalemic activities of Indapamide.
Diflunisal
The therapeutic efficacy of Indapamide can be decreased when used in combination with Diflunisal.
Difluprednate
Difluprednate may increase the hypokalemic activities of Indapamide.
Digitoxin
The risk or severity of adverse effects can be increased when Indapamide is combined with Digitoxin.
Digoxin
The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Indapamide.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Indapamide.
Dihydroergotamine
The metabolism of Indapamide can be decreased when combined with Dihydroergotamine.
Dihydrotachysterol
The risk or severity of hyperkalemia can be increased when Dihydrotachysterol is combined with Indapamide.
Diltiazem
The metabolism of Indapamide can be decreased when combined with Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Indapamide is combined with Dinutuximab.
Diphenhydramine
The serum concentration of Indapamide can be increased when it is combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Indapamide.
Dipivefrin
Dipivefrin may increase the hypokalemic activities of Indapamide.
Dipyridamole
The risk or severity of adverse effects can be increased when Indapamide is combined with Dipyridamole.
Dipyrone
The therapeutic efficacy of Indapamide can be decreased when used in combination with Metamizole.
Disopyramide
Indapamide may increase the QTc-prolonging activities of Disopyramide.
Dobutamine
Dobutamine may increase the hypokalemic activities of Indapamide.
Dofetilide
Indapamide may increase the QTc-prolonging activities of Dofetilide.
Dolasetron
Indapamide may increase the QTc-prolonging activities of Dolasetron.
Domperidone
Indapamide may increase the QTc-prolonging activities of Domperidone.
Dorzolamide
Indapamide may increase the hypotensive activities of Dorzolamide.
Doxazosin
Doxazosin may increase the hypotensive activities of Indapamide.
Doxercalciferol
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Indapamide.
Doxycycline
The metabolism of Indapamide can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Indapamide can be decreased when combined with Doxycycline.
Dronedarone
Indapamide may increase the QTc-prolonging activities of Dronedarone.
Droperidol
Indapamide may increase the QTc-prolonging activities of Droperidol.
Droxicam
The therapeutic efficacy of Indapamide can be decreased when used in combination with Droxicam.
Droxidopa
Droxidopa may increase the hypokalemic activities of Indapamide.
Dulaglutide
The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Indapamide.
Duloxetine
Indapamide may increase the orthostatic hypotensive activities of Duloxetine.
Eliglustat
Indapamide may increase the QTc-prolonging activities of Eliglustat.
Empagliflozin
The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Indapamide.
Enalapril
The risk or severity of hypotension can be increased when Indapamide is combined with Enalapril.
Enalaprilat
The risk or severity of hypotension can be increased when Indapamide is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of hypotension can be increased when Indapamide is combined with Enalaprilat.
Enzalutamide
The serum concentration of Indapamide can be decreased when it is combined with Enzalutamide.
Epinephrine
Epinephrine may increase the hypokalemic activities of Indapamide.
Eplerenone
The risk or severity of adverse effects can be increased when Eplerenone is combined with Indapamide.
Epoprostenol
Indapamide may increase the hypotensive activities of Epoprostenol.
Eprosartan
Indapamide may increase the hypotensive activities of Eprosartan.
Ergocalciferol
The risk or severity of hyperkalemia can be increased when Ergocalciferol is combined with Indapamide.
Erythromycin
The metabolism of Indapamide can be decreased when combined with Erythromycin.
Escitalopram
Indapamide may increase the QTc-prolonging activities of Escitalopram.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Indapamide.
Estrone
Estrone may increase the hypokalemic activities of Indapamide.
Etanercept
The therapeutic efficacy of Indapamide can be decreased when used in combination with Etanercept.
Ethacrynate
The risk or severity of adverse effects can be increased when Indapamide is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Indapamide is combined with Etacrynic acid.
Ethanol
Ethanol may increase the orthostatic hypotensive activities of Indapamide.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Indapamide.
Etodolac
The therapeutic efficacy of Indapamide can be decreased when used in combination with Etodolac.
Etofenamate
The therapeutic efficacy of Indapamide can be decreased when used in combination with Etofenamate.
Etoricoxib
The therapeutic efficacy of Indapamide can be decreased when used in combination with Etoricoxib.
Evening primrose oil
The therapeutic efficacy of Indapamide can be decreased when used in combination with Evening primrose oil.
Exenatide
The therapeutic efficacy of Exenatide can be decreased when used in combination with Indapamide.
Felbinac
The therapeutic efficacy of Indapamide can be decreased when used in combination with Felbinac.
Felodipine
Indapamide may increase the hypotensive activities of Felodipine.
Fenbufen
The therapeutic efficacy of Indapamide can be decreased when used in combination with Fenbufen.
Fenoldopam
Fenoldopam may increase the hypotensive activities of Indapamide.
Fenoprofen
The therapeutic efficacy of Indapamide can be decreased when used in combination with Fenoprofen.
Fenoterol
Fenoterol may increase the hypokalemic activities of Indapamide.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Indapamide.
Ferulic Acid
The therapeutic efficacy of Indapamide can be decreased when used in combination with Ferulic acid.
Fesoterodine
The serum concentration of Indapamide can be increased when it is combined with Fesoterodine.
Flavoxate
The serum concentration of Indapamide can be increased when it is combined with Flavoxate.
Flavoxate Hydrochloride
The serum concentration of Indapamide can be increased when it is combined with Flavoxate.
Flecainide
Indapamide may increase the QTc-prolonging activities of Flecainide.
Floctafenine
The therapeutic efficacy of Indapamide can be decreased when used in combination with Floctafenine.
Fluconazole
The metabolism of Indapamide can be decreased when combined with Fluconazole.
Fludrocortisone
Fludrocortisone may increase the hypokalemic activities of Indapamide.
Flumethasone
Flumethasone may increase the hypokalemic activities of Indapamide.
Flunisolide
Flunisolide may increase the hypokalemic activities of Indapamide.
Flunisolide Anhydrous (obsolete)
Flunisolide may increase the hypokalemic activities of Indapamide.
Fluocinolone Acetonide
Fluocinolone Acetonide may increase the hypokalemic activities of Indapamide.
Fluocinonide
Fluocinonide may increase the hypokalemic activities of Indapamide.
Fluocortolone
Fluocortolone may increase the hypokalemic activities of Indapamide.
Fluorometholone
Fluorometholone may increase the hypokalemic activities of Indapamide.
Fluoxetine
Indapamide may increase the QTc-prolonging activities of Fluoxetine.
Flupenthixol
Indapamide may increase the QTc-prolonging activities of Flupentixol.
FLUPREDNIDENE
Fluprednidene may increase the hypokalemic activities of Indapamide.
Fluprednisolone
Fluprednisolone may increase the hypokalemic activities of Indapamide.
Flurandrenolide
Flurandrenolide may increase the hypokalemic activities of Indapamide.
Flurbiprofen
The therapeutic efficacy of Indapamide can be decreased when used in combination with Flurbiprofen.
Fluticasone
Fluticasone may increase the hypokalemic activities of Indapamide.
Fluticasone Furoate
Fluticasone furoate may increase the hypokalemic activities of Indapamide.
Fluticasone propionate
Fluticasone propionate may increase the hypokalemic activities of Indapamide.
Fluvoxamine
The metabolism of Indapamide can be decreased when combined with Fluvoxamine.
Formestane
Formestane may increase the hypokalemic activities of Indapamide.
Formoterol
Formoterol may increase the hypokalemic activities of Indapamide.
Fosamprenavir
The metabolism of Indapamide can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Indapamide can be increased when it is combined with Fosaprepitant.
Fosinopril
The risk or severity of hypotension can be increased when Indapamide is combined with Fosinopril.
Fosphenytoin
The metabolism of Indapamide can be increased when combined with Fosphenytoin.
Fostamatinib
Fostamatinib may increase the antihypertensive activities of Indapamide.
Furazolidone
Furazolidone may increase the hypotensive activities of Indapamide.
Furosemide
The risk or severity of adverse effects can be increased when Furosemide is combined with Indapamide.
Fusidate
The serum concentration of Indapamide can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Indapamide can be increased when it is combined with Fusidic Acid.
Gadobenate
Indapamide may increase the QTc-prolonging activities of Gadobenic acid.
Gallamine Triethiodide
The serum concentration of Indapamide can be increased when it is combined with Gallamine Triethiodide.
Gemifloxacin
Indapamide may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Indapamide may increase the QTc-prolonging activities of Gemifloxacin.
Glibornuride
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Indapamide.
Gliclazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Indapamide.
Glimepiride
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Indapamide.
Glipizide
The therapeutic efficacy of Glipizide can be decreased when used in combination with Indapamide.
Gliquidone
The therapeutic efficacy of Gliquidone can be decreased when used in combination with Indapamide.
Glyburide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Indapamide.
Glycopyrronium
The serum concentration of Indapamide can be increased when it is combined with Glycopyrronium.
Goserelin
Indapamide may increase the QTc-prolonging activities of Goserelin.
Granisetron
Indapamide may increase the QTc-prolonging activities of Granisetron.
Guanabenz
Guanabenz may increase the hypotensive activities of Indapamide.
Guanadrel
Guanadrel may increase the hypotensive activities of Indapamide.
Guanethidine
Indapamide may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the hypotensive activities of Indapamide.
Halcinonide
Halcinonide may increase the hypokalemic activities of Indapamide.
Halobetasol
Ulobetasol may increase the hypokalemic activities of Indapamide.
Haloperidol
Indapamide may increase the QTc-prolonging activities of Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Indapamide.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Indapamide.
Hexobarbital
Hexobarbital may increase the orthostatic hypotensive activities of Indapamide.
Hexoprenaline
Hexoprenaline may increase the hypokalemic activities of Indapamide.
Homatropine
The serum concentration of Indapamide can be increased when it is combined with Homatropine.
Hydralazine
Hydralazine may increase the hypotensive activities of Indapamide.
Hydrochlorothiazide
Indapamide may increase the hypotensive activities of Hydrochlorothiazide.
Hydrocodone
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Indapamide.
HYDROCODONE POLISTIREX
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Indapamide.
Hydrocortisone
Hydrocortisone may increase the hypokalemic activities of Indapamide.
Hydroflumethiazide
Hydroflumethiazide may increase the hypotensive activities of Indapamide.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Indapamide.
Hyoscyamine
The serum concentration of Indapamide can be increased when it is combined with Hyoscyamine.
Hypoxis hemerocallidea root extract
The serum concentration of Indapamide can be decreased when it is combined with St. John's Wort.
Ibuprofen
The therapeutic efficacy of Indapamide can be decreased when used in combination with Ibuprofen.
Ibutilide
Indapamide may increase the QTc-prolonging activities of Ibutilide.
Icatibant
The therapeutic efficacy of Indapamide can be decreased when used in combination with Icatibant.
Idelalisib
The metabolism of Indapamide can be decreased when combined with Idelalisib.
Iloperidone
Indapamide may increase the QTc-prolonging activities of Iloperidone.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Indapamide.
Imatinib
The metabolism of Indapamide can be decreased when combined with Imatinib.
Imidapril
The risk or severity of hypotension can be increased when Indapamide is combined with Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Indapamide.
Indacaterol
Indacaterol may increase the hypokalemic activities of Indapamide.
Indinavir
The metabolism of Indapamide can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Indapamide can be decreased when combined with Indinavir.
Indobufen
The therapeutic efficacy of Indapamide can be decreased when used in combination with Indobufen.
Indomethacin
The therapeutic efficacy of Indapamide can be decreased when used in combination with Indomethacin.
Indoramin
Indoramin may increase the hypotensive activities of Indapamide.
Insulin Detemir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Indapamide.
Insulin Glargine
The therapeutic efficacy of Insulin Glargine can be decreased when used in combination with Indapamide.
insulin human, rDNA origin
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Indapamide.
Insulin Lispro
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Indapamide.
Insulin, Aspart Protamine, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Indapamide.
Insulin, Aspart, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Indapamide.
Insulin, Glulisine, Human
The therapeutic efficacy of Insulin Glulisine can be decreased when used in combination with Indapamide.
Insulin, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Indapamide.
Insulin, Protamine Lispro, Human
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Indapamide.
Insulin, Regular, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Indapamide.
Ipratropium
The serum concentration of Indapamide can be increased when it is combined with Ipratropium bromide.
Ipratropium cation
The serum concentration of Indapamide can be increased when it is combined with Ipratropium bromide.
Iproniazid
Iproniazid may increase the hypotensive activities of Indapamide.
Irbesartan
Indapamide may increase the hypotensive activities of Irbesartan.
Isavuconazole
The serum concentration of Indapamide can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Indapamide can be decreased when combined with Isavuconazonium.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Indapamide.
Isoetharine
Isoetarine may increase the hypokalemic activities of Indapamide.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Indapamide.
Isoproterenol
Isoprenaline may increase the hypokalemic activities of Indapamide.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Indapamide is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Indapamide is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Indapamide is combined with Isoxsuprine.
Isradipine
The metabolism of Indapamide can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Indapamide can be decreased when combined with Itraconazole.
Ivabradine
Indapamide may increase the arrhythmogenic activities of Ivabradine.
Ivacaftor
The serum concentration of Indapamide can be increased when it is combined with Ivacaftor.
Kebuzone
The therapeutic efficacy of Indapamide can be decreased when used in combination with Kebuzone.
Ketanserin
Ketanserin may increase the hypotensive activities of Indapamide.
Ketoconazole
The metabolism of Indapamide can be decreased when combined with Ketoconazole.
Ketoprofen
The therapeutic efficacy of Indapamide can be decreased when used in combination with Ketoprofen.
Ketorolac
The therapeutic efficacy of Indapamide can be decreased when used in combination with Ketorolac.
Labetalol
Labetalol may increase the hypotensive activities of Indapamide.
Lacidipine
Indapamide may increase the hypotensive activities of Lacidipine.
Latanoprost
Latanoprost may increase the hypotensive activities of Indapamide.
Leflunomide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Leflunomide.
Lenvatinib
Indapamide may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Indapamide may increase the QTc-prolonging activities of Lenvatinib.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Indapamide.
Leuprolide
Indapamide may increase the QTc-prolonging activities of Leuprolide.
Levalbuterol
Levosalbutamol may increase the hypokalemic activities of Indapamide.
Levobunolol
The risk or severity of adverse effects can be increased when Indapamide is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Indapamide.
Levodopa
Indapamide may increase the orthostatic hypotensive activities of Levodopa.
Levofloxacin
Indapamide may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Indapamide may increase the QTc-prolonging activities of Levofloxacin.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Indapamide.
Levomilnacipran
Levomilnacipran may increase the hyponatremic activities of Indapamide.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Indapamide.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Indapamide.
Licorice Allergenic Extract
Licorice may increase the hypokalemic activities of Indapamide.
Limonene, (+)-
The therapeutic efficacy of Indapamide can be decreased when used in combination with (4R)-limonene.
Linagliptin
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Indapamide.
Liraglutide
The therapeutic efficacy of Liraglutide can be decreased when used in combination with Indapamide.
Lisinopril
The risk or severity of hypotension can be increased when Indapamide is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of hypotension can be increased when Indapamide is combined with Lisinopril.
Lithium
Indapamide may decrease the excretion rate of Lithium which could result in a higher serum level.
Lithium Cation
Indapamide may decrease the excretion rate of Lithium which could result in a higher serum level.
Lofexidine
Indapamide may increase the hypotensive activities of Lofexidine.
Lopinavir
The metabolism of Indapamide can be decreased when combined with Lopinavir.
Lornoxicam
The therapeutic efficacy of Indapamide can be decreased when used in combination with Lornoxicam.
Losartan
Losartan may increase the hypotensive activities of Indapamide.
Loteprednol
Loteprednol may increase the hypokalemic activities of Indapamide.
Lovastatin
The metabolism of Indapamide can be decreased when combined with Lovastatin.
Loxoprofen
The therapeutic efficacy of Indapamide can be decreased when used in combination with Loxoprofen.
Luliconazole
The serum concentration of Indapamide can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Indapamide can be increased when combined with Lumacaftor.
Lumefantrine
Indapamide may increase the QTc-prolonging activities of Lumefantrine.
Macitentan
Indapamide may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
The therapeutic efficacy of Indapamide can be decreased when used in combination with Magnesium salicylate.
Manidipine
Indapamide may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Mannitol is combined with Indapamide.
Masoprocol
The therapeutic efficacy of Indapamide can be decreased when used in combination with Masoprocol.
Mecamylamine
The risk or severity of adverse effects can be increased when Indapamide is combined with Mecamylamine.
Meclofenamate
The therapeutic efficacy of Indapamide can be decreased when used in combination with Meclofenamic acid.
Meclofenamic Acid
The therapeutic efficacy of Indapamide can be decreased when used in combination with Meclofenamic acid.
Medrysone
Medrysone may increase the hypokalemic activities of Indapamide.
Mefenamic Acid
The therapeutic efficacy of Indapamide can be decreased when used in combination with Mefenamic acid.
Meloxicam
The therapeutic efficacy of Indapamide can be decreased when used in combination with Meloxicam.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Indapamide.
Mephobarbital
Methylphenobarbital may increase the orthostatic hypotensive activities of Indapamide.
Mepirodipine
Indapamide may increase the antihypertensive activities of Barnidipine.
Mesalamine
The therapeutic efficacy of Indapamide can be decreased when used in combination with Mesalazine.
Metaproterenol
Orciprenaline may increase the hypokalemic activities of Indapamide.
Metformin
The therapeutic efficacy of Metformin can be decreased when used in combination with Indapamide.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Indapamide.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Indapamide.
Methantheline
The serum concentration of Indapamide can be increased when it is combined with Methantheline.
Methazolamide
The risk or severity of adverse effects can be increased when Methazolamide is combined with Indapamide.
Methixene
The serum concentration of Indapamide can be increased when it is combined with Metixene.
Methohexital
Methohexital may increase the orthostatic hypotensive activities of Indapamide.
Methscopolamine
The serum concentration of Indapamide can be increased when it is combined with Methscopolamine.
Methscopolamine Bromide
The serum concentration of Indapamide can be increased when it is combined with Methylscopolamine bromide.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Indapamide.
Methyldopa
Indapamide may increase the hypotensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Indapamide may increase the hypotensive activities of Methyldopa.
Methylene blue
Methylene blue may increase the hypotensive activities of Indapamide.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Indapamide.
Methylprednisolone
Methylprednisolone may increase the hypokalemic activities of Indapamide.
Metipranolol
Indapamide may increase the hypotensive activities of Metipranolol.
Metolazone
Metolazone may increase the hypotensive activities of Indapamide.
Metoprolol
Metoprolol may increase the hypotensive activities of Indapamide.
Metyrosine
Indapamide may increase the hypotensive activities of Metyrosine.
Mibefradil
Indapamide may increase the hypotensive activities of Mibefradil.
Mifepristone
The serum concentration of Indapamide can be increased when it is combined with Mifepristone.
Miglitol
The therapeutic efficacy of Miglitol can be decreased when used in combination with Indapamide.
Miglustat
The therapeutic efficacy of Miglustat can be decreased when used in combination with Indapamide.
Milnacipran
Milnacipran may increase the hyponatremic activities of Indapamide.
Minaprine
Minaprine may increase the hypotensive activities of Indapamide.
Minoxidil
Minoxidil may increase the hypotensive activities of Indapamide.
Mitotane
The serum concentration of Indapamide can be decreased when it is combined with Mitotane.
Moclobemide
Moclobemide may increase the hypotensive activities of Indapamide.
Moexipril
The risk or severity of hypotension can be increased when Indapamide is combined with Moexipril.
Molsidomine
Molsidomine may increase the hypotensive activities of Indapamide.
Mometasone
Mometasone may increase the hypokalemic activities of Indapamide.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Indapamide.
Moxifloxacin
Indapamide may increase the QTc-prolonging activities of Moxifloxacin.
Moxonidine
Moxonidine may increase the hypotensive activities of Indapamide.
MYCOPHENOLATE
The therapeutic efficacy of Indapamide can be decreased when used in combination with Mycophenolic acid.
Mycophenolate Mofetil
The therapeutic efficacy of Indapamide can be decreased when used in combination with Mycophenolate mofetil.
Mycophenolic Acid
The therapeutic efficacy of Indapamide can be decreased when used in combination with Mycophenolic acid.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Indapamide.
Nabumetone
The therapeutic efficacy of Indapamide can be decreased when used in combination with Nabumetone.
Nadolol
Indapamide may increase the hypotensive activities of Nadolol.
Naftifine
The therapeutic efficacy of Indapamide can be decreased when used in combination with Naftifine.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Indapamide.
Naproxen
The therapeutic efficacy of Indapamide can be decreased when used in combination with Naproxen.
Nateglinide
The therapeutic efficacy of Nateglinide can be decreased when used in combination with Indapamide.
Nebivolol
Indapamide may increase the hypotensive activities of Nebivolol.
Nefazodone
The metabolism of Indapamide can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Indapamide can be decreased when combined with Nelfinavir.
Nepafenac
The therapeutic efficacy of Indapamide can be decreased when used in combination with Nepafenac.
Nesiritide
The risk or severity of adverse effects can be increased when Indapamide is combined with Nesiritide.
Netupitant
The serum concentration of Indapamide can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Indapamide can be increased when combined with Nevirapine.
Nialamide
Nialamide may increase the hypotensive activities of Indapamide.
Nicardipine
Nicardipine may increase the hypotensive activities of Indapamide.
Nicorandil
Nicorandil may increase the hypotensive activities of Indapamide.
Nifedipine
The risk or severity of adverse effects can be increased when Indapamide is combined with Nifedipine.
Niflumic Acid
The therapeutic efficacy of Indapamide can be decreased when used in combination with Niflumic Acid.
Nilotinib
Indapamide may increase the QTc-prolonging activities of Nilotinib.
Nilvadipine
Indapamide may increase the hypotensive activities of Nilvadipine.
Nimesulide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Nimesulide.
Nimodipine
Nimodipine may increase the hypotensive activities of Indapamide.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Indapamide.
Nitrendipine
Indapamide may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Indapamide.
Nitroglycerin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Indapamide.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Indapamide.
Norepinephrine
Norepinephrine may increase the hypokalemic activities of Indapamide.
Normethadone
The risk or severity of adverse effects can be increased when Normethadone is combined with Indapamide.
Obinutuzumab
Indapamide may increase the hypotensive activities of Obinutuzumab.
Octotropine Methylbromide
The serum concentration of Indapamide can be increased when it is combined with Anisotropine Methylbromide.
Octylonium
The serum concentration of Indapamide can be increased when it is combined with Otilonium.
Oenothera biennis seed extract
The therapeutic efficacy of Indapamide can be decreased when used in combination with Evening primrose oil.
Ofloxacin
Indapamide may increase the QTc-prolonging activities of Ofloxacin.
Olaparib
The metabolism of Indapamide can be decreased when combined with Olaparib.
Olmesartan
Olmesartan may increase the hypotensive activities of Indapamide.
Olodaterol
Olodaterol may increase the hypokalemic activities of Indapamide.
Olopatadine
The therapeutic efficacy of Indapamide can be decreased when used in combination with Olopatadine.
Olsalazine
The therapeutic efficacy of Indapamide can be decreased when used in combination with Olsalazine.
Ondansetron
Indapamide may increase the QTc-prolonging activities of Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Opium is combined with Indapamide.
Orphenadrine
The serum concentration of Indapamide can be increased when it is combined with Orphenadrine.
Osimertinib
The serum concentration of Indapamide can be increased when it is combined with Osimertinib.
Ouabain
The risk or severity of adverse effects can be increased when Indapamide is combined with Ouabain.
Ovine Digoxin Immune Fab
The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin Immune Fab (Ovine).
Oxaprozin
The therapeutic efficacy of Indapamide can be decreased when used in combination with Oxaprozin.
Oxcarbazepine
The risk or severity of hyponatremia can be increased when Indapamide is combined with Oxcarbazepine.
Oxitropium
The serum concentration of Indapamide can be increased when it is combined with Oxitropium.
Oxprenolol
Indapamide may increase the hypotensive activities of Oxprenolol.
Oxybutynin
The serum concentration of Indapamide can be increased when it is combined with Oxybutynin.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Indapamide.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Indapamide.
Oxyphenbutazone
The therapeutic efficacy of Indapamide can be decreased when used in combination with Oxyphenbutazone.
Oxyphenonium
The serum concentration of Indapamide can be increased when it is combined with Oxyphenonium.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Indapamide.
Palbociclib
The serum concentration of Indapamide can be increased when it is combined with Palbociclib.
Paliperidone
Indapamide may increase the QTc-prolonging activities of Paliperidone.
Palmidrol
The therapeutic efficacy of Indapamide can be decreased when used in combination with Palmidrol.
Pancuronium
The serum concentration of Indapamide can be increased when it is combined with Pancuronium.
Pancuronium Bromide
The serum concentration of Indapamide can be increased when it is combined with Pancuronium.
Panobinostat
Indapamide may increase the QTc-prolonging activities of Panobinostat.
Papaverine
The risk or severity of adverse effects can be increased when Indapamide is combined with Papaverine.
Paramethasone
Paramethasone may increase the hypokalemic activities of Indapamide.
Parecoxib
The therapeutic efficacy of Indapamide can be decreased when used in combination with Parecoxib.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Indapamide.
Pargyline
Pargyline may increase the hypotensive activities of Indapamide.
Paricalcitol
The risk or severity of hyperkalemia can be increased when Paricalcitol is combined with Indapamide.
Paroxetine
Paroxetine may increase the hyponatremic activities of Indapamide.
Parthenolide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Parthenolide.
Pazopanib
Indapamide may increase the QTc-prolonging activities of Pazopanib.
Penbutolol
Indapamide may increase the hypotensive activities of Penbutolol.
Pentamidine
Indapamide may increase the QTc-prolonging activities of Pentamidine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Indapamide.
Pentobarbital
The metabolism of Indapamide can be increased when combined with Pentobarbital.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Indapamide.
Perflutren
Indapamide may increase the QTc-prolonging activities of Perflutren.
Perindopril
The risk or severity of hypotension can be increased when Indapamide is combined with Perindopril.
Phenelzine
Phenelzine may increase the hypotensive activities of Indapamide.
Phenformin
The therapeutic efficacy of Phenformin can be decreased when used in combination with Indapamide.
Phenobarbital
The metabolism of Indapamide can be increased when combined with Phenobarbital.
Phenoxybenzamine
Indapamide may increase the hypotensive activities of Phenoxybenzamine.
Phentolamine
Phentolamine may increase the hypotensive activities of Indapamide.
Phentolamine Mesylate
Phentolamine may increase the hypotensive activities of Indapamide.
Phenylbutazone
The therapeutic efficacy of Indapamide can be decreased when used in combination with Phenylbutazone.
Phenylpropanolamine
Phenylpropanolamine may increase the hypokalemic activities of Indapamide.
Phenytoin
The metabolism of Indapamide can be increased when combined with Phenytoin.
Pimecrolimus
The therapeutic efficacy of Indapamide can be decreased when used in combination with Pimecrolimus.
Pimozide
Indapamide may increase the QTc-prolonging activities of Pimozide.
Pinacidil
Pinacidil may increase the hypotensive activities of Indapamide.
Pindolol
Indapamide may increase the hypotensive activities of Pindolol.
Pioglitazone
The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Indapamide.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Indapamide.
Pipecuronium
The serum concentration of Indapamide can be increased when it is combined with Pipecuronium.
Pirbuterol
Pirbuterol may increase the hypokalemic activities of Indapamide.
Pirenzepine
The serum concentration of Indapamide can be increased when it is combined with Pirenzepine.
Pirfenidone
The therapeutic efficacy of Indapamide can be decreased when used in combination with Pirfenidone.
Pirinitramide
The risk or severity of adverse effects can be increased when Piritramide is combined with Indapamide.
Piroxicam
The therapeutic efficacy of Indapamide can be decreased when used in combination with Piroxicam.
Piroxicam-Beta-Cyclodextrin
The therapeutic efficacy of Indapamide can be decreased when used in combination with Piroxicam.
Polythiazide
Indapamide may increase the hypotensive activities of Polythiazide.
Posaconazole
The metabolism of Indapamide can be decreased when combined with Posaconazole.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Indapamide.
Pramlintide
The therapeutic efficacy of Pramlintide can be decreased when used in combination with Indapamide.
Prasterone
Prasterone may increase the hypokalemic activities of Indapamide.
Prazosin
Prazosin may increase the hypotensive activities of Indapamide.
Prednicarbate
Prednicarbate may increase the hypokalemic activities of Indapamide.
Prednisolone
Prednisolone may increase the hypokalemic activities of Indapamide.
Prednisone
Prednisone may increase the hypokalemic activities of Indapamide.
Pregnenolone
Pregnenolone may increase the hypokalemic activities of Indapamide.
Primaquine
Indapamide may increase the QTc-prolonging activities of Primaquine.
Primidone
The metabolism of Indapamide can be increased when combined with Primidone.
Procainamide
Indapamide may increase the QTc-prolonging activities of Procainamide.
Procaine
Procaine may increase the hypotensive activities of Indapamide.
Procarbazine
Procarbazine may increase the hypotensive activities of Indapamide.
Procaterol
Procaterol may increase the hypokalemic activities of Indapamide.
Procyclidine
The serum concentration of Indapamide can be increased when it is combined with Procyclidine.
Profenamine
The serum concentration of Indapamide can be increased when it is combined with Ethopropazine.
Promazine
Indapamide may increase the QTc-prolonging activities of Promazine.
Propafenone
Indapamide may increase the QTc-prolonging activities of Propafenone.
Propantheline
The serum concentration of Indapamide can be increased when it is combined with Propantheline.
Propantheline Bromide
The serum concentration of Indapamide can be increased when it is combined with Propantheline.
Propiverine
The serum concentration of Indapamide can be increased when it is combined with Propiverine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Indapamide.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Indapamide.
Propranolol
Propranolol may increase the hypotensive activities of Indapamide.
Proscillaridin
The risk or severity of adverse effects can be increased when Indapamide is combined with Proscillaridin.
Quetiapine
Indapamide may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Indapamide may increase the QTc-prolonging activities of Quetiapine.
Quinapril
The risk or severity of hypotension can be increased when Indapamide is combined with Quinapril.
Quinidine
Indapamide may increase the QTc-prolonging activities of Quinidine.
Quinine
Indapamide may increase the QTc-prolonging activities of Quinine.
Racepinephrine
Racepinephrine may increase the hypokalemic activities of Indapamide.
Ramipril
The risk or severity of hypotension can be increased when Indapamide is combined with Ramipril.
Ranolazine
The metabolism of Indapamide can be decreased when combined with Ranolazine.
Rasagiline
Rasagiline may increase the hypotensive activities of Indapamide.
Regular Insulin, Human
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Indapamide.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Indapamide.
Repaglinide
The therapeutic efficacy of Repaglinide can be decreased when used in combination with Indapamide.
Rescinnamine
The risk or severity of hypotension can be increased when Indapamide is combined with Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Indapamide.
Resveratrol
The therapeutic efficacy of Indapamide can be decreased when used in combination with Resveratrol.
Rifabutin
The metabolism of Indapamide can be increased when combined with Rifabutin.
Rifampin
The metabolism of Indapamide can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Indapamide can be increased when combined with Rifapentine.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Indapamide.
Rimexolone
Rimexolone may increase the hypokalemic activities of Indapamide.
Riociguat
Indapamide may increase the hypotensive activities of Riociguat.
Risperidone
Indapamide may increase the hypotensive activities of Risperidone.
Ritodrine
Ritodrine may increase the hypokalemic activities of Indapamide.
Rituximab
Indapamide may increase the hypotensive activities of Rituximab.
Rofecoxib
The therapeutic efficacy of Indapamide can be decreased when used in combination with Rofecoxib.
Ropinirole
The risk or severity of adverse effects can be increased when Ropinirole is combined with Indapamide.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Indapamide.
Rosiglitazone
The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Indapamide.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Indapamide.
Rucaparib
The metabolism of Indapamide can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Indapamide.
Salicylamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Salicylamide.
Salicylic Acid
The therapeutic efficacy of Indapamide can be decreased when used in combination with Salicylic acid.
Salmeterol
Salmeterol may increase the hypokalemic activities of Indapamide.
Salsalate
The therapeutic efficacy of Indapamide can be decreased when used in combination with Salsalate.
Saquinavir
The metabolism of Indapamide can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Indapamide can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Indapamide can be decreased when used in combination with Sarilumab.
Saxagliptin
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Indapamide.
Saxagliptin Anhydrous
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Indapamide.
Scopolamine
The serum concentration of Indapamide can be increased when it is combined with Scopolamine.
Scopolamine Hydrobromide
The serum concentration of Indapamide can be increased when it is combined with Scopolamine.
Secobarbital
Secobarbital may increase the orthostatic hypotensive activities of Indapamide.
Selegiline
Selegiline may increase the hypotensive activities of Indapamide.
Selexipag
Indapamide may increase the hypotensive activities of Selexipag.
Serratiopeptidase
The therapeutic efficacy of Indapamide can be decreased when used in combination with Serrapeptase.
Sertraline
Sertraline may increase the hyponatremic activities of Indapamide.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Indapamide.
Sildenafil
Sildenafil may increase the antihypertensive activities of Indapamide.
Siltuximab
The serum concentration of Indapamide can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Indapamide can be increased when it is combined with Simeprevir.
Sitagliptin
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Indapamide.
Sitagliptin Phosphate
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Indapamide.
Sodium Phosphate
Indapamide may increase the nephrotoxic activities of Sodium phosphate.
Sodium Phosphate, Monobasic
Indapamide may increase the nephrotoxic activities of Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Indapamide may increase the nephrotoxic activities of Sodium phosphate.
Solifenacin
The serum concentration of Indapamide can be increased when it is combined with Solifenacin.
Sotalol
Indapamide may increase the QTc-prolonging activities of Sotalol.
Spirapril
The risk or severity of hypotension can be increased when Indapamide is combined with Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Indapamide.
ST. JOHN'S WORT EXTRACT
The serum concentration of Indapamide can be decreased when it is combined with St. John's Wort.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Indapamide.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Indapamide.
Sulfasalazine
The therapeutic efficacy of Indapamide can be decreased when used in combination with Sulfasalazine.
Sulfisoxazole
The metabolism of Indapamide can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Indapamide is combined with Sulpiride.
Suprofen
The therapeutic efficacy of Indapamide can be decreased when used in combination with Suprofen.
Tacalcitol
The risk or severity of hyperkalemia can be increased when Tacalcitol is combined with Indapamide.
Tadalafil
Tadalafil may increase the antihypertensive activities of Indapamide.
Talinolol
Indapamide may increase the hypotensive activities of Talinolol.
Tamsulosin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Indapamide.
Tapentadol
The risk or severity of adverse effects can be increased when Tapentadol is combined with Indapamide.
Telaprevir
The metabolism of Indapamide can be decreased when combined with Telaprevir.
Telavancin
Indapamide may increase the QTc-prolonging activities of Telavancin.
Telithromycin
The metabolism of Indapamide can be decreased when combined with Telithromycin.
Telmisartan
Indapamide may increase the hypotensive activities of Telmisartan.
Tenoxicam
The therapeutic efficacy of Indapamide can be decreased when used in combination with Tenoxicam.
Terazosin
The risk or severity of adverse effects can be increased when Indapamide is combined with Terazosin.
Terbutaline
Terbutaline may increase the hypokalemic activities of Indapamide.
Terbutaline Sulfate
Terbutaline may increase the hypokalemic activities of Indapamide.
Teriflunomide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Teriflunomide.
Terlipressin
Indapamide may increase the hypotensive activities of Terlipressin.
Tetrabenazine
Indapamide may increase the QTc-prolonging activities of Tetrabenazine.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Indapamide.
Theodrenaline
Indapamide may increase the hypotensive activities of Theodrenaline.
Theophylline
Theophylline may increase the antihypertensive activities of Indapamide.
Theophylline anhydrous
Theophylline may increase the antihypertensive activities of Indapamide.
Thiamylal
Thiamylal may increase the orthostatic hypotensive activities of Indapamide.
Thiopental
Thiopental may increase the orthostatic hypotensive activities of Indapamide.
Thiopental Sodium
Thiopental may increase the orthostatic hypotensive activities of Indapamide.
Thioridazine
Indapamide may increase the QTc-prolonging activities of Thioridazine.
Tiaprofenic Acid
The therapeutic efficacy of Indapamide can be decreased when used in combination with Tiaprofenic acid.
Tibolone
Indapamide may increase the hypotensive activities of Tibolone.
Ticlopidine
The metabolism of Indapamide can be decreased when combined with Ticlopidine.
Timolol
Timolol may increase the hypotensive activities of Indapamide.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Indapamide.
Tiotropium
The serum concentration of Indapamide can be increased when it is combined with Tiotropium.
Tixocortol
Tixocortol may increase the hypokalemic activities of Indapamide.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Indapamide.
Tocilizumab
The serum concentration of Indapamide can be decreased when it is combined with Tocilizumab.
Tolazamide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Indapamide.
Tolazoline
Tolazoline may increase the hypotensive activities of Indapamide.
Tolbutamide
The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Indapamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Indapamide.
Tolfenamic Acid
The therapeutic efficacy of Indapamide can be decreased when used in combination with Tolfenamic Acid.
Tolmetin
The therapeutic efficacy of Indapamide can be decreased when used in combination with Tolmetin.
Toloxatone
Toloxatone may increase the hypotensive activities of Indapamide.
Tolterodine
The serum concentration of Indapamide can be increased when it is combined with Tolterodine.
Toremifene
Indapamide may increase the hypercalcemic activities of Toremifene.
Torsemide
Torasemide may increase the hypotensive activities of Indapamide.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Indapamide.
Trandolapril
The risk or severity of hypotension can be increased when Indapamide is combined with Trandolapril.
Tranilast
The therapeutic efficacy of Indapamide can be decreased when used in combination with Tranilast.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Indapamide.
Travoprost
Travoprost may increase the hypotensive activities of Indapamide.
Treprostinil
Treprostinil may increase the hypotensive activities of Indapamide.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Indapamide.
Triamcinolone
Triamcinolone may increase the hypokalemic activities of Indapamide.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Indapamide.
Tribenoside
The therapeutic efficacy of Indapamide can be decreased when used in combination with Tribenoside.
Tricalcium Phosphate
Indapamide may decrease the excretion rate of Calcium Phosphate which could result in a higher serum level.
Trichlormethiazide
Indapamide may increase the hypotensive activities of Trichlormethiazide.
Trihexyphenidyl
The serum concentration of Indapamide can be increased when it is combined with Trihexyphenidyl.
Trihexyphenidyl Hydrochloride
The serum concentration of Indapamide can be increased when it is combined with Trihexyphenidyl.
Trimethaphan
The serum concentration of Indapamide can be increased when it is combined with Trimethaphan.
Troglitazone
The therapeutic efficacy of Troglitazone can be decreased when used in combination with Indapamide.
Tropicamide
The serum concentration of Indapamide can be increased when it is combined with Tropicamide.
Trospium
The serum concentration of Indapamide can be increased when it is combined with Trospium.
Tubocurarine
The serum concentration of Indapamide can be increased when it is combined with Tubocurarine.
Umeclidinium
The serum concentration of Indapamide can be increased when it is combined with Umeclidinium.
UNOPROSTONE
Indapamide may increase the hypotensive activities of Unoprostone.
Urapidil
Urapidil may increase the hypotensive activities of Indapamide.
Valdecoxib
The therapeutic efficacy of Indapamide can be decreased when used in combination with Valdecoxib.
Valsartan
Valsartan may increase the hypotensive activities of Indapamide.
Vandetanib
Indapamide may increase the QTc-prolonging activities of Vandetanib.
Vardenafil
Vardenafil may increase the antihypertensive activities of Indapamide.
Vecuronium
The serum concentration of Indapamide can be increased when it is combined with Vecuronium.
Vemurafenib
The serum concentration of Indapamide can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Indapamide can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Indapamide can be decreased when combined with Verapamil.
Vilanterol
Vilanterol may increase the hypokalemic activities of Indapamide.
Vildagliptin
The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Indapamide.
Vincamine
Indapamide may increase the hypotensive activities of Vincamine.
Vinpocetine
Indapamide may increase the hypotensive activities of Vinpocetine.
Vitamin D
The risk or severity of hyperkalemia can be increased when Vitamin D is combined with Indapamide.
Voriconazole
The metabolism of Indapamide can be decreased when combined with Voriconazole.
Xylometazoline
Indapamide may increase the hypotensive activities of Xylometazoline.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Indapamide.
Zileuton
The therapeutic efficacy of Indapamide can be decreased when used in combination with Zileuton.
Ziprasidone
Indapamide may increase the QTc-prolonging activities of Ziprasidone.
Zofenopril
The risk or severity of hypotension can be increased when Indapamide is combined with Zofenopril.
Zomepirac
The therapeutic efficacy of Indapamide can be decreased when used in combination with Zomepirac.
Zuclopenthixol
Indapamide may increase the QTc-prolonging activities of Zuclopenthixol.
